Cinkate Medicine Chemical Intermediate (Shanghai) Co., Ltd. agreed to acquire 15% stake in Suzhou Changzheng Cinkate Pharmaceutical Co., Ltd. from JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHSE:600200) for CNY 33 million on January 31, 2023. For the year ended, December 31, 2022, Suzhou Changzheng Cinkate Pharmaceutical Co., Ltd. total asset is CNY 465.30 million and net asset is CNY 94.54 million. The transaction was approved by Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. the first session of the 10th directorate.